The UK National Screening Committee has recommended that the faecal immunochemical test (FIT) be the primary screening test for bowel cancer and NHS England remains absolutely committed to implementing FIT in 2018/19.<\/p>
<\/p>
NHS England is working with Public Health England to finalise a number of practical arrangements around sensitivity, production and distribution of FIT kits, and diagnostic and pathology workforce capacity to ensure that when FIT is implemented, it is sustainable.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-03-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-03-20T17:31:43.397Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-03-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Bowel Cancer: Screening"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "What the timetable is for the implementation of the faecal immunochemical test for bowel cancer screening.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3968", "label" : {"_value" : "Biography information for Stephen Lloyd"} } , "tablingMemberConstituency" : {"_value" : "Eastbourne"} , "tablingMemberPrinted" : [{"_value" : "Stephen Lloyd"} ], "uin" : "904478"} , {"_about" : "http://data.parliament.uk/resources/866427", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/866427/answer", "answerText" : {"_value" : "
Value Added Tax (VAT) paid by the National Health Service on the purchase of medicines is fully incorporated within the funding allocated to the NHS each year.<\/p>
As is the case with many other goods and services, VAT is chargeable at 20% to members of the public when purchasing over the counter and non-prescription medicines.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-03-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-03-20T15:37:51.743Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-03-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care what assessment he has made of the effect of charging VAT on the affordability and accessibility of medicines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4389", "label" : {"_value" : "Biography information for Ruth Cadbury"} } , "tablingMemberConstituency" : {"_value" : "Brentford and Isleworth"} , "tablingMemberPrinted" : [{"_value" : "Ruth Cadbury"} ], "uin" : "904465"} , {"_about" : "http://data.parliament.uk/resources/864293", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/864293/answer", "answerText" : {"_value" : "
NHS England has advised that following the hon. Member\u2019s letter to the Chief Executive of NHS England, they have launched an investigation.<\/p>
<\/p>
They also have advised that they are unable to provide further information until the investigation is concluded.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-03-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-03-20T16:42:20.673Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-03-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "East Lancashire Clinical Commissioning Group: Salute"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what representations his Department has received on recent work undertaken by East Lancashire Clinical Commissioning Group and the charity Salute.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1538", "label" : {"_value" : "Biography information for Rosie Cooper"} } , "tablingMemberConstituency" : {"_value" : "West Lancashire"} , "tablingMemberPrinted" : [{"_value" : "Rosie Cooper"} ], "uin" : "132777"} , {"_about" : "http://data.parliament.uk/resources/864294", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/864294/answer", "answerText" : {"_value" : "
It is important that clinical commissioning groups (CCGs) should respond to constituent casework in a timely manner.<\/p>
<\/p>
NHS England has advised that the Chief Officer for Lancashire CCG, Mike McQuire, has written to the hon. Member about the role of NHS Midlands and Lancashire Commissioning Support Unit in working with NHS West Lancashire CCG to produce responses to correspondence from hon. Members.<\/p>
<\/p>
We understand he has set out the process for dealing with letters and the responsibilities of the respective organisations involved in providing accurate responses to hon. Members or constituents, and has requested a further meeting with the hon. Member to discuss the matter further.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-03-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-03-20T16:33:13.677Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-03-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Midlands and Lancashire Commissioning Support Unit"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will make an assessment of the validity of Midlands and Lancashire Commissioning Support Unit's policy of allowing themselves up to 40 working days to respond to constituent casework regardless of whether an investigation is needed.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1538", "label" : {"_value" : "Biography information for Rosie Cooper"} } , "tablingMemberConstituency" : {"_value" : "West Lancashire"} , "tablingMemberPrinted" : [{"_value" : "Rosie Cooper"} ], "uin" : "132778"} , {"_about" : "http://data.parliament.uk/resources/864434", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/864434/answer", "answerText" : {"_value" : "
In August 2017, Crohn\u2019s and Colitis UK in partnership with the Royal College of General Practitioners (RCGP) launched a new Inflammatory Bowel Disease (IBD) toolkit: an online resource for general practitioners (GPs) and healthcare professionals designed to improve understanding of Crohn\u2019s Disease and Ulcerative Colitis, collectively known as IBD. The Toolkit was developed as part of a 12 month project on IBD, and includes a range of resources for GPs to improve detection of inflammatory bowel disease and to support primary care clinicians in treating, managing and referring patients with the condition.<\/p>
<\/p>
The Toolkit was promoted at events across the United Kingdom and an IBD Twitter chat with an expert panel was held in February 2018. The Toolkit, regional events and Twitter session were all promoted to GPs via the RCGP website and newsletter and more widely by Crohn\u2019s and Colitis UK. The Toolkit can be found at the following link:<\/p>
<\/p>
www.rcgp.org.uk/clinical-and-research/resources/toolkits/inflammatory-bowel-disease-toolkit.aspx<\/a><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-03-20", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-20T16:31:16.827Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Inflammatory Bowel Disease"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that GPs receive a copy of Crohn's & Colitis UK's latest Inflammatory Bowel Disease toolkit to improve (a) awareness, (b) early diagnosis and (b) treatment plans for that condition.", "registeredInterest" : {"_value" : "true", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4464", "label" : {"_value" : "Biography information for Melanie Onn"}
}
, "tablingMemberConstituency" : {"_value" : "Great Grimsby"}
, "tablingMemberPrinted" : [{"_value" : "Melanie Onn"}
], "uin" : "132917"}
, {"_about" : "http://data.parliament.uk/resources/864441", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/864441/answer", "answerText" : {"_value" : " Estimates of undiagnosed HIV infection are not available by Nomenclature of Territorial Units for Statistics (NUTS) 1 region.<\/p> <\/strong><\/p> There may be some regional differences in treatment rates or drugs used based on variations in patient demographics or the available drug contracts.<\/p> <\/p> Regional HIV networks determine prescribing guidelines which align with national commissioning policies for antiretroviral therapies. These guidelines are overseen by the HIV Clinical Reference Group \u2013 which includes strong patient representation - who provide clinical advice on HIV treatment issues and raise concerns from the community should there be perceived issue around equitable access.<\/p> <\/p> Working closely with Public Health England (PHE), NHS England has produced a clinical dashboard that summarises clinical performance at the trust level. PHE prepares and analyses all the data that feeds into the Clinical Reference Group HIV dashboard. Two dashboard indicators measure anti-retroviral therapy coverage among all people accessing HIV care and among people with a low CD4 count (indicative of immunosuppression). Further information on the dashboard is available here:<\/p> <\/p> https://www.england.nhs.uk/commissioning/spec-services/npc-crg/spec-dashboards/<\/a><\/p> <\/p> <\/p> Data are not available by NUTS for the proportion of people living with diagnosed HIV infection who are not receiving antiretroviral therapy treatment.<\/p> <\/p> Antiretroviral therapy is now so effective that people receiving treatment can expect to have a near normal life expectancy. Consequently, the proportion of people receiving treatment continues to rise each year since death rates remain low. The higher antiretroviral therapy coverage rate observed in some regions is partially due to the longer history of the epidemic in these areas.<\/p> <\/p> <\/p> British HIV Association guidelines have progressively reduced the threshold at which patients may begin antiretroviral therapy. In 2018, NHS England announced routine commissioning of \u2018Immediate Access to Antiretroviral Therapy\u2019 from 1 April 2018.<\/p> <\/p> https://www.england.nhs.uk/publication/clinical-commissioning-policy-immediate-antiretroviral-therapy-for-treatment-of-hiv-1-in-adults-and-adolescents/<\/a><\/p> <\/p> This enables all patients to access treatment at the point of diagnosis or at the time the patient wishes to commence treatment. It has also clarified the position on the funding of antiretroviral therapy for immediate treatment among patients newly diagnosed with HIV.<\/p> <\/p> NHS England and PHE keep under review data on the rates of uptake of antiretroviral treatment and will continue to do so to identify any unwarranted variation.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-03-20", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "132925"}
, {"_value" : "132926"}
, {"_value" : "132927"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-20T16:36:27.01Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "HIV Infection"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate has been made of the number of people with undiagnosed HIV, broken down by NUTS 1 region, in each year since 2013-14.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1533", "label" : {"_value" : "Biography information for Dame Diana Johnson"}
}
, "tablingMemberConstituency" : {"_value" : "Kingston upon Hull North"}
, "tablingMemberPrinted" : [{"_value" : "Diana Johnson"}
], "uin" : "132924"}
, {"_about" : "http://data.parliament.uk/resources/864442", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/864442/answer", "answerText" : {"_value" : " Estimates of undiagnosed HIV infection are not available by Nomenclature of Territorial Units for Statistics (NUTS) 1 region.<\/p> <\/strong><\/p> There may be some regional differences in treatment rates or drugs used based on variations in patient demographics or the available drug contracts.<\/p> <\/p> Regional HIV networks determine prescribing guidelines which align with national commissioning policies for antiretroviral therapies. These guidelines are overseen by the HIV Clinical Reference Group \u2013 which includes strong patient representation - who provide clinical advice on HIV treatment issues and raise concerns from the community should there be perceived issue around equitable access.<\/p> <\/p> Working closely with Public Health England (PHE), NHS England has produced a clinical dashboard that summarises clinical performance at the trust level. PHE prepares and analyses all the data that feeds into the Clinical Reference Group HIV dashboard. Two dashboard indicators measure anti-retroviral therapy coverage among all people accessing HIV care and among people with a low CD4 count (indicative of immunosuppression). Further information on the dashboard is available here:<\/p> <\/p> https://www.england.nhs.uk/commissioning/spec-services/npc-crg/spec-dashboards/<\/a><\/p> <\/p> <\/p> Data are not available by NUTS for the proportion of people living with diagnosed HIV infection who are not receiving antiretroviral therapy treatment.<\/p> <\/p> Antiretroviral therapy is now so effective that people receiving treatment can expect to have a near normal life expectancy. Consequently, the proportion of people receiving treatment continues to rise each year since death rates remain low. The higher antiretroviral therapy coverage rate observed in some regions is partially due to the longer history of the epidemic in these areas.<\/p> <\/p> <\/p> British HIV Association guidelines have progressively reduced the threshold at which patients may begin antiretroviral therapy. In 2018, NHS England announced routine commissioning of \u2018Immediate Access to Antiretroviral Therapy\u2019 from 1 April 2018.<\/p> <\/p> https://www.england.nhs.uk/publication/clinical-commissioning-policy-immediate-antiretroviral-therapy-for-treatment-of-hiv-1-in-adults-and-adolescents/<\/a><\/p> <\/p> This enables all patients to access treatment at the point of diagnosis or at the time the patient wishes to commence treatment. It has also clarified the position on the funding of antiretroviral therapy for immediate treatment among patients newly diagnosed with HIV.<\/p> <\/p> NHS England and PHE keep under review data on the rates of uptake of antiretroviral treatment and will continue to do so to identify any unwarranted variation.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-03-20", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "132924"}
, {"_value" : "132926"}
, {"_value" : "132927"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-20T16:36:27.07Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "HIV Infection: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps (a) his Department, (b) NHS England and (c) Public Health England is taking to ensure the equity of access to antiretoroviral therapy in the regions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1533", "label" : {"_value" : "Biography information for Dame Diana Johnson"}
}
, "tablingMemberConstituency" : {"_value" : "Kingston upon Hull North"}
, "tablingMemberPrinted" : [{"_value" : "Diana Johnson"}
], "uin" : "132925"}
, {"_about" : "http://data.parliament.uk/resources/864443", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/864443/answer", "answerText" : {"_value" : " Estimates of undiagnosed HIV infection are not available by Nomenclature of Territorial Units for Statistics (NUTS) 1 region.<\/p> <\/strong><\/p> There may be some regional differences in treatment rates or drugs used based on variations in patient demographics or the available drug contracts.<\/p> <\/p> Regional HIV networks determine prescribing guidelines which align with national commissioning policies for antiretroviral therapies. These guidelines are overseen by the HIV Clinical Reference Group \u2013 which includes strong patient representation - who provide clinical advice on HIV treatment issues and raise concerns from the community should there be perceived issue around equitable access.<\/p> <\/p> Working closely with Public Health England (PHE), NHS England has produced a clinical dashboard that summarises clinical performance at the trust level. PHE prepares and analyses all the data that feeds into the Clinical Reference Group HIV dashboard. Two dashboard indicators measure anti-retroviral therapy coverage among all people accessing HIV care and among people with a low CD4 count (indicative of immunosuppression). Further information on the dashboard is available here:<\/p> <\/p> https://www.england.nhs.uk/commissioning/spec-services/npc-crg/spec-dashboards/<\/a><\/p> <\/p> <\/p> Data are not available by NUTS for the proportion of people living with diagnosed HIV infection who are not receiving antiretroviral therapy treatment.<\/p> <\/p> Antiretroviral therapy is now so effective that people receiving treatment can expect to have a near normal life expectancy. Consequently, the proportion of people receiving treatment continues to rise each year since death rates remain low. The higher antiretroviral therapy coverage rate observed in some regions is partially due to the longer history of the epidemic in these areas.<\/p> <\/p> <\/p> British HIV Association guidelines have progressively reduced the threshold at which patients may begin antiretroviral therapy. In 2018, NHS England announced routine commissioning of \u2018Immediate Access to Antiretroviral Therapy\u2019 from 1 April 2018.<\/p> <\/p> https://www.england.nhs.uk/publication/clinical-commissioning-policy-immediate-antiretroviral-therapy-for-treatment-of-hiv-1-in-adults-and-adolescents/<\/a><\/p> <\/p> This enables all patients to access treatment at the point of diagnosis or at the time the patient wishes to commence treatment. It has also clarified the position on the funding of antiretroviral therapy for immediate treatment among patients newly diagnosed with HIV.<\/p> <\/p> NHS England and PHE keep under review data on the rates of uptake of antiretroviral treatment and will continue to do so to identify any unwarranted variation.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-03-20", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "132924"}
, {"_value" : "132925"}
, {"_value" : "132927"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-20T16:36:27.167Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "HIV Infection: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what proportion of people diagnosed with HIV infection are not receiving antiretroviral treatment by NUTS 1 region in each year since 2013-14.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1533", "label" : {"_value" : "Biography information for Dame Diana Johnson"}
}
, "tablingMemberConstituency" : {"_value" : "Kingston upon Hull North"}
, "tablingMemberPrinted" : [{"_value" : "Diana Johnson"}
], "uin" : "132926"}
, {"_about" : "http://data.parliament.uk/resources/864444", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/864444/answer", "answerText" : {"_value" : " Estimates of undiagnosed HIV infection are not available by Nomenclature of Territorial Units for Statistics (NUTS) 1 region.<\/p> <\/strong><\/p> There may be some regional differences in treatment rates or drugs used based on variations in patient demographics or the available drug contracts.<\/p> <\/p> Regional HIV networks determine prescribing guidelines which align with national commissioning policies for antiretroviral therapies. These guidelines are overseen by the HIV Clinical Reference Group \u2013 which includes strong patient representation - who provide clinical advice on HIV treatment issues and raise concerns from the community should there be perceived issue around equitable access.<\/p> <\/p> Working closely with Public Health England (PHE), NHS England has produced a clinical dashboard that summarises clinical performance at the trust level. PHE prepares and analyses all the data that feeds into the Clinical Reference Group HIV dashboard. Two dashboard indicators measure anti-retroviral therapy coverage among all people accessing HIV care and among people with a low CD4 count (indicative of immunosuppression). Further information on the dashboard is available here:<\/p> <\/p>